Company Search:
Advanced Search
Sponsored Links
Oncimmune Holdings PLC Company Snapshot
Oncimmune Holdings PLC operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncimmune Holdings PLC with three other pharmaceutical manufacturers in Europe: Enorama Pharma AB of SWEDEN (2020 sales of 2.15 million Swedish Kronor [US$250,459.66 ] ), Epigenomics AG of GERMANY (842,000.00 Euros [US$980,205.88 ] of which 69% was Product sales (own and third party)), and Provexis PLC (£347,937.00 [US$479,912.98 ] ).

Sales Analysis. Sales were up sharply during the second fiscal quarter of 2021 versus the previous year's second quarter. During the second fiscal quarter of 2021, sales at Oncimmune Holdings PLC totalled £1.83 million. This is an increase of 493.2% from the £308,000.00 in sales at the company during the second quarter of 2020. Sales increased substantially in 2020: Oncimmune Holdings PLC reported sales of £509,000.00 (US$702.07 thousand) for the fiscal year ending May of 2020. This represents an increase of 197.7% versus 2019, when the company's sales were £171,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oncimmune Holdings PLC
  Stock Performance Chart for Oncimmune Holdings PLC
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 180.00p
(Figures in Pounds Sterling)
1 Week -2.7%   13 Weeks 2.9%  
4 Weeks 0.0%   52 Weeks 1.4%  
Oncimmune Holdings PLC Key Data:
  Ticker: ONC Country: United Kingdom
  Exchanges: LON Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2020 Sales 509,000
(Year Ending Jan 2021).
Employees: 72
  Currency: Pounds Sterling Market Cap: 114,552,765
  Fiscal Yr Ends: May Shares Outstanding: 63,640,425
  Share Type: Ordinary Closely Held Shares: 30,467,037
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.